share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A:超过5%持股股东披露文件(修正)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%)等
美股SEC公告 ·  02/23 22:23
Moomoo AI 已提取核心信息
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
2024年2月23日,Yaletown Bros. Ventures Ltd及其成员Matthew Friesen和Bradley Friesen与美国证券交易委员会(SEC)共同提交了第四号修正案《13D附表》。该附表指示了他们对Bruush Oral Care Inc.普通股的所有权的变化,该组之前报告的持股比例在63%至82%之间,现在持有公司约2.8%的普通股,共2810602股。这一变化是在2024年2月16日至2月22日期间的一系列公开市场交易之后发生的,报告人出售了2919500股。交易价格介于0.0575美元至0.0825美元之间。通过Yaletown Bros. Ventures Ltd,Friesens已停止拥有超过Bruush Oral Care普通股5%的有益所有权。该申报文件代表了报告人《13D附表》的最后一项修正,标志着他们在公司投资的大幅减少。
2024年2月23日,Yaletown Bros. Ventures Ltd及其成员Matthew Friesen和Bradley Friesen与美国证券交易委员会(SEC)共同提交了第四号修正案《13D附表》。该附表指示了他们对Bruush Oral Care Inc.普通股的所有权的变化,该组之前报告的持股比例在63%至82%之间,现在持有公司约2.8%的普通股,共2810602股。这一变化是在2024年2月16日至2月22日期间的一系列公开市场交易之后发生的,报告人出售了2919500股。交易价格介于0.0575美元至0.0825美元之间。通过Yaletown Bros. Ventures Ltd,Friesens已停止拥有超过Bruush Oral Care普通股5%的有益所有权。该申报文件代表了报告人《13D附表》的最后一项修正,标志着他们在公司投资的大幅减少。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息